Abstract 1 A fully integrated system that combines extended gate field-effect transistor (EGFET)-based 2 potentiometric biosensors and electrochemical impedance spectroscopy (EIS)-based biosensors has been 3 demonstrated. This integrated configuration enables the sequential measurement of the same 4 immunological binding event on the same sensing surface, and consequently sheds light on the 5 fundamental origins of sensing signals produced by FET and EIS biosensors, as well as the correlation 6 between the two. Detection of both BSA/anti-BSA model system in buffer solution and bovine 7 parainfluenza antibodies in complex blood plasma samples were demonstrated using the integrated 8 biosensors. Comparison of the EGFET and EIS sensor responses reveals similar dynamic ranges, while 9 equivalent circuit modeling of the EIS response shows that the commonly reported total impedance 10 change (ΔZtotal) is dominated by the change in charge transfer resistance (Rct) rather than surface 11 capacitance (Csurface). Using electrochemical kinetics and the Butler-Volmer equation, we unveil that the 12 surface potential and charge transfer resistance, measured by potentiometric and impedance biosensors, 13 respectively, are, in fact, intrinsically linked. This observation suggests that there is no significant gain in 14 using FET/EIS integrated system and leads to the demonstration that low-cost EGFET biosensors are 15 sufficient as a detection tool to resolve the charge information of biomolecules for practical sensing 16 applications. 17 18 Text 19
The ability to detect biochemical species rapidly without complicated sample preparations in a centralized 20 laboratory is essential for medical care, disease diagnosis, food safety and environmental monitoring. 21
Optical biosensing that requires secondary markers to label target biomolecules (e.g., fluorescence 22 spectroscopy) is time consuming in sample preparation and response. 1 In contrast, label-free electrical 23 biosensors are particularly promising as point-of-care sensor devices since they can be miniaturized 24 through cost-effective microfabrication. Relying directly on the immunological affinity between 1 immobilized surface probes and targets in an analyte solution, the resulting change of the surface 2
properties is amplified and converted to an electrical output signal by a transducer. Potentiometric and 3 impedance biosensors are two of the most common transducers for label-free biosensing. Potentiometric 4 biosensors detect the change of surface potential under DC operation due to the attachment of charged 5 target biomolecules to the probes on the sensing surface, and are most commonly implemented in the 6 form of ion-sensitive FETs (ISFETs) or in a similar but a simplified configuration -extended gate FETs 7 (EGFETs). [2] [3] [4] [5] Alternatively, impedance biosensors use electrochemical impedance spectroscopy (EIS) to 8 measure the change of electrical current and, in turn, the electrical impedance of a biological interface 9 under DC bias and AC oscillation. 6-9 Cost-effective potentiometric and impedance sensors are capable of 10 label-free operation that both simplifies the sample preparation steps and enable on-site detection with 11 shorter turnaround time. 12
Although various nanomaterial-based ISFETs have been used for potentiometric biosensors including 13 silicon nanowires, 10 graphene, 11 carbon nanotubes, 12 we have reported that the sensitivity of a 14 potentiometric biosensor is independent of the choice of the transducer, and instead relies only on the 15 sensing surface. 4 Moreover, ISFETs require a sophisticated encapsulation scheme to protect the 16 semiconductor device from exposure to the liquid environment that can hamper reliability and stability. 13 17
Consequently, if either the sensing surface or the readout component fails, the entire ISFET sensor 18 becomes unusable. EGFET biosensors, by contrast, provide a simpler and a more robust design for liquid 19 phase sensing by separating the sensing chip (an extended gate) from the readout transducer (FET), and 20 the sensitivity is comparable to the conventional ISFET. 4 Moreover, the EGFET is a promising tool for 21 disease diagnosis with a comparable performance to ELISA and SPR. 5 Finally, since the transducer is 22 separated from the sensing surface, the EGFET configuration readily enables the integration of 23 potentiometric sensors with other sensor platforms. 24 1 surface. Under faradaic operation involving redox couples, the measured impedance spectrum can be 2 further analyzed using an equivalent circuit model. Two of the most important parameters, charge transfer 3 resistance (Rct) and surface capacitance (Csurface) can be resolved in this way. The change of surface 4 potential and the formation of the biomolecular layer will prevent the redox species from approaching the 5 working electrode due to electrostatic repulsion and steric hindrance, respectively. 7 The phenomenon is 6 often reflected in an increase of the Rct which dominates the overall measured impedance. 7
In this letter, we demonstrate a fully integrated system that combines both two-terminal EGFET-based 8 potentiometric and three-terminal EIS-based impedance biosensing on a shared active sensing surface. 9
This system enables the sequential measurement of the same binding event on the same sensing surface 10 using two different sensing techniques. Consequently, we are able to perform a fundamental investigation 11 into the origins of the sensing signal produced by FET and EIS biosensors. A bovine serum albumin 12 (BSA) versus antibody-BSA (anti-BSA) prototype system was used as the test vehicle for the integrated 13
biosensors. In addition, detection of bovine parainfluenza antibodies in a complex blood system with 14 hemagglutinin-neuraminidase (HN) has also been demonstrated. Comparison of the EGFET and EIS 15 sensor responses reveals similar dynamic ranges, and motivates our study of the relationship between 16 surface potential and impedance, which is explained by electrochemical kinetics and the Butler-Volmer 17
equation. 18
All the chemicals and proteins were purchased from Sigma-Aldrich and used as received. The sensor chip 19 was fabricated on a borofloat wafer. The metallic structures including Au micro-strip working electrode 20 (WE), Au (Ti/Au 10/90 nm) counter electrode (CE) and Pt (Ti/Pt 10/90 nm) on-chip pseudo-reference 21 electrode (RE) were deposited and patterned using e-beam evaporation and photolithography, respectively. 22
A commercial n-MOSFET (VN0104, Supertex) was used as the transducer for EGFET biosensors and the 23 I-V characterization was measured using a Keithley 4200-SCS semiconductor analyzer. EIS biosensors 24 were characterized using a Gamry Interface 1000 potentiostat. The WE was coated with o-aminobenzoic 25 1 mV/s). The BSA proteins (1% in PBS) were immobilized onto the sensing surface through amine 2 coupling using NHS/EDC. The contact time for BSA protein immobilization is 30 minutes. The sensing 3 surface was later deactivated and blocked using 1M ethanolamine-HCl solution for 30 minutes. This 4 sensing surface was exposed to anti-BSA dilutions in PBS with 20 min contact time. The detailed 5 experimental methods of HN/BPIV3 sensing can be found in the Supplementary Information. A 10 mM 6 hexaammineruthenium (III) chloride in PBS was used as the redox couple. In the EGFET sensor, the Au 7 active sensing surface serves as the WE, i.e. extended gate of a MOSFET. A DC voltage sweep is applied 8 to the liquid through a commercial Ag/AgCl RE. For EIS sensor, the aforementioned Au WE is the active 9 sensing surface. On-chip Pt pseudo-RE and Au CE are used. The signal, i.e. surface potential, of 10 potentiometric sensors was extracted from the Id-Vref curve as the Vref value when Id = 1 μA. The EIS 11 spectra were modeled using ZView (Scribner Associates Inc.) by minimizing the chi square value. The 12 detailed methods and parameters for the electrical measurement can be found in Supplementary  13 Information. 14 Comparing EGFET and EIS sensors, the Au working electrode plays a common role: an active sensing 15 surface and WE. As a result, a fully integrated sensing system combining EGFET potentiometric and EIS 16 impedance biosensors can be achieved by sharing a common Au WE as schematically shown in Figure 1a . 17 Using this integrated system, the steps of chemical functionalization and biomolecular attachment can be 18 achieved for both sensors concurrently. Furthermore, this design offers a direct comparison between 19 potentiometric and impedance sensors because the same binding events will be measured on a shared 20 sensing surface. 21
The optical image of the sensor chip is shown in Figure 1c and the enlarged view of Au micro-strip WE in 22 Figure 1d . The dimension of the Au micro-strip is 50 μm long and 0.8 μm wide (4x10 -7 cm 2 ). The use of a 23 microscale electrode provides the benefit of minimizing the mass transfer limited behaviors in EIS at low 24 frequency, due to the decreased diffusion length around the miniaturized working electrode. 9, 14, 15 The 25 conventional Randle circuit model comprises of series resistance (Rs), surface capacitance (Csurface usually 1 modeled using constant phase elements, CPE), Warburg resistance (W) and charge transfer resistance 2 (Rct). When the nominal size of the working electrode decreases, the diffusion layer thickness decreases, 3 and the current is less dependent on the diffusion of reacting species toward the WE. 16 As a result, the 4 mass transfer dominated W becomes negligible and the Randle circuit can be simplified to a simple RC 5 circuit as shown in Figure 1b . 17, 18 The measured impedance spectra will be modeled using the simplified 6 circuit model to extract the circuit elements, including Rct. Using an n-channel MOSFET as the transducer, 7 a positive voltage is applied to the solution for FET biosensor measurement and, therefore, a redox probe 8 that has negative redox potential is desired. As a result, hexaammineruthenium (III) chloride, which has 9 both negative reduction and oxidation potentials, qualifies for the application in this study. The FET/EIS integrated sensor's responses to the BSA versus anti-BSA system are shown in Figure 2 . 18
The Id-Vref curve of the transistor will shift horizontally depending on the magnitude and the polarity of 19 the change of surface potential on the Au sensing surface. This change of surface potential due to the 1 attachment of charged antibodies to the WE, i.e. extended gate, was obtained using the change of the 2 FET's threshold voltage (Vth). Figure 2a depicts the shift of Id-Vref curves of the potentiometric sensor in 3 the positive direction in response to the increasing concentration of anti-BSA in the PBS, indicating that 4 the anti-BSA (isoelectric point 4.8 -5.2) is negatively charged in the PBS buffer (pH 7.4). 19 Figure 2b  5 shows the change of surface potential measured by FET potentiometric sensor versus anti-BSA 6 concentration in linear scale and logarithmic scale (inset of Figure 2b) . A typical Langmuir adsorption 7 response with a gradual saturation toward high antibody concentration was observed. 4 Measuring the 8 same binding event at the working electrode, the change of EIS spectra with respect to anti-BSA 9 concentration is presented in a Nyquist plot (Figure 2c ). Taking advantage of the miniaturized working 10 electrode, no obvious mass transfer limited characteristics were observed in the recorded impedance 11 spectra, except a slight deviation from the semi-circle under low frequency (< 5 Hz) and a further 12 optimization of the WE may be needed. As a result, the change of surface properties on the sensing 13 surface is mainly reflected through the change of Rct. As the anti-BSA concentration increases, the overall 14 size of the semicircle increases, indicating an increase of Rct and total impedance. By fitting the 15 impedance spectra with the equivalent circuit model (Figure 1b) , biomolecular binding-related circuit 16 elements, Rct and Csurface, could be extracted. However, Csurface is relatively insensitive to the attachment of 17 antibodies to the semipermeable biolayer ( Figure S1 ). Figure 2d shows the relationship between Rct and 18 anti-BSA concentration. A similar Langmuir adsorption behavior with saturation at high anti-BSA 19 concentration was again observed, showing integrated operation of a FET/EIS biosensor system. 20
Furthermore, the similar response obtained from both sensing platforms suggests a possible correlation 21 between surface potential and the impedance, which is explored in the following. According to classical electrochemical kinetics, the electrical current that flows through the electrode is 8 governed by the effective potential on the electrode surface. 20 This relationship is expressed by the Butler-9
Volmer equation. Under bias conditions that deviate from equilibrium, i.e. Tafel behavior, the Butler-10
Volmer equation that links the charge transfer resistance and the surface potential can be simplified to: 20,21 11
where R0 = Eapp/FAK 0 C, F is Faraday constant, A is the area of the working electrode, k 0 is the standard 13 rate constant, C is the concentration of the redox couple species at the electrolyte-electrode interface, 14 transfer coefficient α is commonly assumed to be 0.5 for a symmetrical energy barrier, Eapp is the bias 15 applied to the system, ΔV is the change of surface potential on the working electrode, q is the elementary 16 charge of an electron, kB is Boltzmann's constant and T is the temperature. It is reported that k 0 exhibits a 1 wide range from 10 -9 to several hundred cm/s depending on the choice of the redox couple, the surface 2 morphology of the WE, the formation of the biolayer, different charge transfer mechanisms, buffer 3 concentration, etc. 20,22,23 In effect, the Butler-Volmer equation predicts that Rct is exponentially related to 4 the change of surface potential (ΔV). Figure 3 shows the relationship between Rct, measured with EIS, and 5 the exponentiation of ΔV, i.e. exp(αqΔV/kBT), obtained from the FET. A high linearity is observed which 6 agrees well with the prediction of Butler-Volmer theory. The fitted R0 is 1.43 x 10 6 Ω and is comparable 7 to the calculated value of 1.04 x 10 6 Ω, where A = 4 x10 -7 cm 2 , k 0 is 1 cm/s for a simple electron 8 transfer, 23 and C is 10 -5 mol/cm 3 . In the case of affinity sensors, the ΔV results from the binding of 9 charged biomolecules to the surface, i.e. WE. EGFET sensors directly measure this surface potential 10 change, which concurrently influences the electrical current and the resulting impedance measured by EIS 11 sensors by increasing the hindrance for redox species from reaching the WE. This finding confirms that 12 the origin of the sensing signals for both potentiometric biosensors and impedance biosensors is the 13 change of surface potential. Also, the signal output from potentiometric biosensors can be linked to that of 14 impedance biosensors using the Butler-Volmer equation. 15
Beyond the BSA/anti-BSA system, a complex serological system of bovine hemagglutinin-neuraminidase 16 (HN) versus antibodies of bovine parainfluenza virus protein type-3 (BPIV3) in blood plasma samples 17 was also tested. 24 HN protein was immobilized on the shared WE via amine coupling as the probe against 18 the BPIV3 proteins in the analyte solution. Similar to BSA/aBSA system, similar trends of the dynamic 19 range of FET and EIS sensors were observed. Again, the relationship between signals from potentiometric 20 and impedance sensors, ΔV and Rct, respectively, are linked and agrees well with Butler-Volmer theory 21 (see Supplementary Information and Figure S2 ). The results further confirm the correlation between 22 potentiometric and impedance sensors and suggest that the electrical sensor is a promising tool for the 23 disease diagnostic applications. The details of HN protein immobilization, sensing surface blocking and 24 detection of antibodies of BPIV3 can be found in Supplementary Information. Impedance spectroscopy is a powerful tool to analyze the interfacial properties for corrosion, coatings, 7 batteries, solar cells, etc. through complex analysis of the frequency responses. [25] [26] [27] [28] [29] Intuitively, surface 8 impedance measured in EIS biosensors is expected to respond to both charge and mass of the 9 biomolecules. However, for biosensor applications, the frequency response of surface capacitance is 10 insensitive to the formation of the biomolecular layer on the sensing surface because: (1) the biolayer is 11 semipermeable and is not a good capacitor; and, (2) the double layer capacitance dominates. 6,7,18 As a 12 result, it is difficult to resolve the mass-related properties of biomolecules alongside their charge 13 information using impedance biosensors. The surface potential related Rct remains the dominating 14 contribution for the sensing signal. In other words, the FET/EIS integrated sensing system provides little 15 extra value in monitoring the charge information of biomolecules since the origin of the signal is linked. 16 1 biosensing applications. 2
To further illustrate their suitability for cost-effective and rapid point-of-care detection, large area Au 3 extended gate sensor chips (0.1 cm 2 ) were also prepared without the use of photolithography steps, 4
instead using e-beam metal evaporation and patterning with shadow masks. The DC operation of the 5 EGFET at steady state is not limited by the diffusion and, therefore, alleviates the constraints of using and Au micro-strip (red circle). The BSA/anti-BSA sensitivities using either approach are comparable. 14
15
In conclusion, biosensing using an integrated two-sensor system that combines EGFET-based 1 potentiometric biosensors and EIS-based impedimetric biosensors has been demonstrated. This integrated 2 two-sensor system enables the direct comparison between two sensing techniques by monitoring the same 3 biological layers on the sensing surface. The correlation between sensor signalsthat is, surface potential 4
and Rct from FET and EIS, respectivelywas linked using the Butler-Volmer equation. The results 5 suggest that both FET and EIS biosensors are sensitive to the change of surface potential due to the 6 attachment of charged biomolecules to the sensing surface, whereas the mass-dependent value of Csurface 7 does not vary significantly. For the detection of charge properties of biomolecules, the EIS/FET 8
integrated sensing system provides little extra advantage. Therefore, EGFET biosensors are inherently 9 sufficient as electrical transducers for label-free biomolecule detection, while providing the added 10 benefits of rapid response and low-cost scalability. For scenarios where detailed information about both 11 charge and mass properties of biomolecular targets is required, the FET/EIS integrated sensing system 12 that we have proposed may be deployed to great effect. Future studies involving complex biofluids and 13 advanced modeling will help to identify how the mass-related properties extracted from EIS can be 14 
